한빛사논문 | BRIC

안민애 님의 논문 목록

성균관대학교 의과대학, 삼성서울병원

Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5FU in HER2-positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
- Clin. Cancer Res., February 17 2025 | https://doi.org/10.1158/1078-0432.CCR-24-3528
- 2025-02
- 의약학
- 한빛사논문
Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric cancer
- Cancer Discov., Feb 06 2024, | https://doi.org/10.1158/2159-8290.CD-23-0857
- 2024-02
- 의약학
- 한빛사논문
Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing
- Exp. Mol. Med., 2022 Dec;54(12):2128-2134 | https://doi.org/10.1038/s12276-022-00892-z
- 2022-12
- 의약학
- 한빛사논문
Early Tumor-Immune Microenvironmental Remodeling and Response to Frontline Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
- Cancer Discov., Published first December 21, 2021 | https://doi.org/10.1158/2159-8290.CD-21-0888
- 2021-12
- 의약학
- 한빛사논문
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD1 therapy
- Ann. Oncol., Available online 25 October 2021 | https://doi.org/10.1016/j.annonc.2021.10.009
- 2021-10
- 의약학
- 한빛사논문
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer
- Cancer Discov., April 12, 2021 | https://doi.org/10.1158/2159-8290.CD-21-0219
- 2021-04
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기